Skip to main content

Type 2 Diabetes News

Type 2 Diabetes is a chronic condition involving high blood sugar levels and reduced production and responsiveness to insulin.     

Michael writes about his diagnosis with type 2 diabetes, and how he used a CGM to put his type 2 diabetes into remission
New updates include time-in-range goals, heart health benefits of GLP-1 agonist Trulicity, and recommendation of GLP-1 agonist Victoza for children and teens with type 2...
An oral (pill) version of Ozempic, Rybelsus, becomes the first GLP-1 agonist pill for type 2 diabetes
Comedian and actor Billy Gardell spoke with diaTribe about his journey with type 2 diabetes and how he has changed both his outlook and his habits
New partnerships with Tidepool Loop, plus two new models of virtual clinical care
What I've Learned From 70,000 Hours Wearing CGM - A Video Presentation at Thriveabetes 2019
New guidelines from ADA and EASD focus on GLP-1 agonists and SGLT-2 inhibitors to improve heart and kidney health
These new rules will save both consumers and health plan providers thousands of dollars a year through pre-deductible coverage of chronic condition treatments
Under the 2020 health plan, Walmart employees get an incredible network of high-quality healthcare professionals. Ask your boss if this type of investment in employee...
The diaTribe Foundation’s sixth annual “Solvable Problems in Diabetes” in Barcelona brought together more than 140 leaders to discuss challenges and opportunities in...
A bipartisan legislation, which would have protected patients from surprise medical bills, is blocked from passing this year
Powerful A1C-lowering from Victoza now an option for ages 10-17, in addition to metformin and insulin
Xofluza was recently approved to treat the flu in higher-risk populations – people with diabetes or other chronic conditions, and people over age 65 – and to prevent...
Low-cost monthly subscription services from mySugr, One Drop, DarioHealth, and Livongo
As we demand more nutritious and sustainable food, big food companies must make adjustments to their products, practices, and marketing
Maria shares her experiences and strategies for managing blood sugar levels while studying abroad
A trial is enrolling over 3,000 individuals living with type 2 diabetes and chronic kidney disease
Control-IQ the first AID system with automatic correction boluses and no fingersticks CGM (Dexcom G6); cleared for those ages 14 and older; launch in January 2020
The new BioSense ketone breath meter offers unlimited, effortless ketone measurements – just blow into the device
Adam’s presentation at Friends for Life 2019

Pages